- ICH GCP
- Register voor klinische proeven in de VS.
- Klinische proef NCT03741842
"COMBO-KEY" - A Home Visiting and Phone Coaching Programme to Promote Stroke Survivors' Recovery
25 augustus 2022 bijgewerkt door: Suzanne HS Lo, Chinese University of Hong Kong
"COMBO-KEY" (Coaching Ongoing Momentum Building On stroKe rEcovery journeY) - A Home Visiting and Phone Coaching Programme to Promote Stroke Survivors' Recovery: A Territory-wide Project
Building confidence and capabilities to transfer rehabilitative knowledge and skills into lifestyle-workable strategies for changing health behaviours among stroke survivors are important to optimise health outcomes and reduce risks of recurrent stroke.
The aim of this project is to promote stroke survivors' health by building confidence and positive expectations of recovery outcomes, and enabling their engagement in stroke self-management behaviours.
Studie Overzicht
Gedetailleerde beschrijving
A randomised controlled trial will be conducted to determine the effectiveness of a programme "Coaching Ongoing Momentum Building On stroKe rEcovery journeY" ("COMBO-KEY"), a home visiting and phone coaching programme, on community-dwelling stroke survivors' self-efficacy, outcome expectation, and engagement in stroke self-management behaviours.
An estimated sample of 134 stroke survivors will be recruited.
COMBO-KEY will be underpinned by Bandura's constructs of self-efficacy and outcome expectation.
It will be delivered by trained coaches.
Outcomes will be measured at baseline and immediately after completion of the programme.
Generalised estimating equations model will be used to assess the differential changes in outcome variables from pre-test to post-test between the intervention and control groups with adjustment for their baseline levels.
Studietype
Ingrijpend
Inschrijving (Werkelijk)
134
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Hong Kong, Hongkong
- Community settings
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar en ouder (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Ja
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- Clinically diagnosed with stroke
- 18 years old or above
- Community dwelling
- Have a modified Rankin Scale score equal to or greater than 3 (moderate to severe disability)
- Have a Montreal Cognitive Assessment score >20
Exclusion Criteria:
- Have severe dysphasia
- Are diagnosed with a mental illness
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Onderzoek naar gezondheidsdiensten
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
---|---|
Experimenteel: COMBO-KEY group
The participants in the intervention group will receive a home visiting and phone coaching self-management programme (Coaching Ongoing Momentum Building On stroKe rEcovery journeY "COMBO-KEY") which is underpinned by Bandura's constructs of self-efficacy and outcome expectation.
|
The intervention will last for eight weeks with four home visits and five phone coaching sessions.
It will also consist of a 4-item resource package for stroke survivors (including a stroke self-management and self-discovery workbook, a health and life planning toolkit, and videos on sharing of experience by survivors who managed their post-stroke challenges successfully, and a stroke self-management quick reference guide).
A telephone hotline for survivors and caregivers to seek information and support related to stroke self-management will also be established.
A programme protocol will be developed to ensure the consistent delivery of the programme.
|
Geen tussenkomst: Usual care group
The participants in the usual care group will receive usual rehabilitation services offered, including services by a community rehabilitation network such as exercise training, physical rehabilitation, or activities organised by stroke support groups.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in the level of self-efficacy in performing daily functional activities and self management
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 13-item Chinese version of the Stroke Self-Efficacy Questionnaire will be used.
The items assess the stroke survivors' confidence in performing self-management behaviours over a 0-no confidence to 10-very confident points scale.
All item scores are summed (total 0-130).
Higher scores indicate higher self-efficacy.
|
Change from baseline level to immediately after completion of the intervention
|
Secundaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
---|---|---|
Change in the level of outcome expectation of stroke self-management behaviours
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 11-item Chinese version of the Stroke Self-management Outcome Expectation Scale will be used.
The items assess the stroke survivors' confidence in the occurrence of outcomes after performing the self-management behaviours.
All item scores are summed (total 0-110; each item is rated over 0-Strongly disagree to 10-Strongly agree).
Higher scores represent higher confidence towards positive outcome.
|
Change from baseline level to immediately after completion of the intervention
|
Change in the level of satisfaction with performance of stroke self-management behaviours
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 11-item Chinese version of the Stroke Self-management Behaviours Performance Scale will be used.
The items ask the stroke survivors' satisfaction with their performance of self-management behaviours.
All item scores are summed (total 0-110; each item is rated over 0-Strongly disagree to 10-Strongly agree).
Higher scores represent higher satisfaction.
|
Change from baseline level to immediately after completion of the intervention
|
Change in the level of health-related quality of life
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 49-item Chinese version of the Stroke Specific Quality of Life Scale will be used.
The items ask the stroke survivors' agreement to the health conditions and difficulties in performing the tasks described.
All item scores are summed (total 49-245; 1-Strongly disagree/couldn't do it to 5-Strongly agree/no trouble).
Higher scores represent higher health-related quality of life.
|
Change from baseline level to immediately after completion of the intervention
|
Change in the level of depressive symptoms
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 15-item Chinese version of the Geriatric Depression Scale will be used.
The stroke survivors will be asked for agreement to the items based on their condition (total 0-15; Yes-1 score or No-0 score).
A score of 5-8 indicates mild depression; 9-11 moderate depression; and 12-15 severe depression.
|
Change from baseline level to immediately after completion of the intervention
|
Change in the level of community reintegration
Tijdsspanne: Change from baseline level to immediately after completion of the intervention
|
The 11-item Chinese version of the Reintegration to Normal Living Index will be used.
The stroke survivors will be asked the extent to which the items described their situation (total 11-55; 1-A small extent to 5-A great extent).
Higher scores represent better community reintegration.
|
Change from baseline level to immediately after completion of the intervention
|
Satisfaction with the programme (Participants in the intervention group)
Tijdsspanne: Immediately after completion of the intervention
|
Rate the ease of use and relevance of contents and resources, arrangement, and coaches' performance on a 5-Likert point (1-Very dissatisfied to 5-Very satisfied)
|
Immediately after completion of the intervention
|
Usage of the resource package (Participants in the intervention group)
Tijdsspanne: Immediately after completion of the intervention
|
Frequency (minutes) of using the resource package per week
|
Immediately after completion of the intervention
|
Level of goal attainment (Participants in the intervention group)
Tijdsspanne: Immediately after completion of the intervention
|
Rate the level of goal attainment on a scale from 0-Not attained, 1-Partially attained, to 2-Completely attained
|
Immediately after completion of the intervention
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Publicaties en nuttige links
De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start (Werkelijk)
1 maart 2019
Primaire voltooiing (Werkelijk)
30 juni 2022
Studie voltooiing (Werkelijk)
30 juni 2022
Studieregistratiedata
Eerst ingediend
12 november 2018
Eerst ingediend dat voldeed aan de QC-criteria
13 november 2018
Eerst geplaatst (Werkelijk)
15 november 2018
Updates van studierecords
Laatste update geplaatst (Werkelijk)
29 augustus 2022
Laatste update ingediend die voldeed aan QC-criteria
25 augustus 2022
Laatst geverifieerd
1 augustus 2022
Meer informatie
Termen gerelateerd aan deze studie
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- 01170718
Plan Individuele Deelnemersgegevens (IPD)
Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?
NEE
Informatie over medicijnen en apparaten, studiedocumenten
Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel
Nee
Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct
Nee
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .
Klinische onderzoeken op COMBO-KEY
-
University of MinnesotaVoltooidOnderrug pijn | Chronische pijn | Nek pijnVerenigde Staten
-
Prof. Dr. Martin WabitschCharite University, Berlin, Germany; University of Leipzig; University of Ulm; University... en andere medewerkersVoltooidObesitas | Extreme zwaarlijvigheidDuitsland
-
Children's Mercy Hospital Kansas CityVoltooidGastro-oesofageale reflux | Gezinstevredenheid | VoedingsstoornisVerenigde Staten
-
University of Texas at AustinWerving
-
University of VirginiaNational Institutes of Health (NIH); National Institute on Aging (NIA)WervingHartfalen met verminderde ejectiefractieVerenigde Staten
-
Prof. Stephen LeeVoltooidCoronaire trombose | Coronaire restenoseHongkong
-
Gen-Probe, IncorporatedVoltooidChlamydia trachomatis | Neisseria Gonorrhoeae-infectieVerenigde Staten
-
Gisela Grotewold ChelimskyBeëindigdDyspepsie | Misselijkheid | Prikkelbare Darm Syndroom | Functionele gastro-intestinale stoornissen | Nervus vagus autonome stoornisVerenigde Staten
-
Gen-Probe, IncorporatedVoltooidGonorroe | Chlamydia-infectiesVerenigde Staten
-
Abbott Diagnostics DivisionVoltooidMenselijke immunodeficiëntievirussenVerenigde Staten